On the watchlist are Unilever shares which could stand up after the company effectively abandoned its plans to buy GSK's consumer healthcare business, saying that it would not raise its 50 billion pound offer that GSK previously rejected. 
Neutral
Neutral
GSK
Neutral
Neutral
GSK
Neutral
Neutral
Unilever